Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02307 (long intergenic non-protein coding RNA 2307) is a human long intergenic non-coding RNA, distinguished as a member of the lincRNA family. LINC02307 does not encode a protein and is notable for its autonomous transcription from a genomic region that does not overlap any protein-coding genes[3][1][5]. Like other lincRNAs, it is implicated in the regulation of gene expression at the transcriptional and epigenetic levels, and may have enhancer-associated functions contributing to the modulation of neighboring gene activity[1]. While lincRNAs broadly have roles in human diseases—including cancer—the specific biological and disease-related functions of LINC02307 itself have not been reported or characterized in detail in current literature[3][1][5].
Not applicable, as no drugs targeting this RNA are documented.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2307 (LINC02307).